ArticlePloS one2018

Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.

Sophie Marbaix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.